Salvador Pedraza Selected Research

Desmodus rotundus salivary plasminogen activator alpha 1

12/2016	Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).
9/2012	Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
6/2012	Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase.
2/2009	Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvador Pedraza Research Topics

Disease

28	Stroke (Strokes) 01/2022 - 07/2004
22	Ischemic Stroke 01/2022 - 07/2004
6	Obesity 12/2021 - 11/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 04/2013
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 10/2007
2	Pathologic Constriction (Stenosis) 12/2016 - 06/2012
2	Neoplasms (Cancer) 05/2016 - 01/2016
2	Infarction (Infarctions) 04/2015 - 04/2012
1	Body Weight (Weight, Body) 01/2022
1	Weight Loss (Weight Reduction) 01/2020
1	Atrial Fibrillation 01/2020
1	Lacunar Stroke 01/2019
1	Ischemia 01/2018
1	Cerebral Infarction 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2016
1	Brain Neoplasms (Brain Tumor) 05/2016
1	Brain Edema (Cerebral Edema) 05/2016
1	Edema (Dropsy) 05/2016
1	Lung Neoplasms (Lung Cancer) 05/2016
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Gambling (Pathological Gambling) 05/2016
1	Cognitive Dysfunction 11/2014
1	Insulin Resistance 11/2014
1	Iron Overload 11/2014
1	Rupture 12/2011
1	Breast Neoplasms (Breast Cancer) 12/2011
1	Breast Diseases (Breast Disease) 12/2011
1	Brain Ischemia (Cerebral Ischemia) 07/2004
1	Hemorrhage 07/2004

Drug/Important Bio-Agent (IBA)

19	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 07/2004
12	Biomarkers (Surrogate Marker)IBA 11/2018 - 10/2009
4	Desmodus rotundus salivary plasminogen activator alpha 1IBA 12/2016 - 02/2009
3	gadobutrolIBA 01/2019 - 04/2013
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 12/2021 - 10/2020
2	IronIBA 02/2016 - 11/2014
2	gadofosveset trisodium (MS 325)FDA Link 01/2016 - 04/2013
1	CarbonIBA 12/2021
1	Tryptophan (L-Tryptophan)FDA Link 12/2021
1	Histidine (L-Histidine)FDA Link 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	SmokeIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Silybin (Lagosa)IBA 05/2016
1	OsteocalcinIBA 05/2016
1	CholesterolIBA 02/2016
1	thiamine triphosphorate (TTP)IBA 11/2015
1	Interleukin-10 (Interleukin 10)IBA 06/2013
1	AlbuminsIBA 04/2013
1	Contrast MediaIBA 04/2013
1	SiliconesIBA 12/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2009
1	Fibronectins (Fibronectin)IBA 07/2004

Therapy/Procedure

8	Therapeutics 01/2020 - 10/2009
3	Thrombolytic Therapy 04/2015 - 07/2004
2	Aftercare (After-Treatment) 01/2022 - 07/2004
2	Radiotherapy 05/2016 - 01/2016
1	Long-Term Care 11/2021
1	Thrombectomy 01/2021
1	Transplantation 10/2020
1	Bariatric Surgery 01/2020
1	CT protocol 01/2017
1	Combined Modality Therapy 05/2016
1	Drug Therapy (Chemotherapy) 01/2016
1	Breast Implants (Breast Implant) 12/2011
1	Prostheses and Implants (Prosthesis) 12/2011